BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 15709983)

  • 1. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
    Jalving M; Koornstra JJ; De Jong S; De Vries EG; Kleibeuker JH
    Aliment Pharmacol Ther; 2005 Feb; 21(4):321-39. PubMed ID: 15709983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemoprevention: future direction of colorectal cancer prevention.
    Zhou P; Cheng SW; Yang R; Wang B; Liu J
    Eur J Cancer Prev; 2012 May; 21(3):231-40. PubMed ID: 22456425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of colorectal cancer.
    Das D; Arber N; Jankowski JA
    Digestion; 2007; 76(1):51-67. PubMed ID: 17947819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
    Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
    J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies with the azoxymethane-rat preclinical model for assessing colon tumor development and chemoprevention.
    Reddy BS
    Environ Mol Mutagen; 2004; 44(1):26-35. PubMed ID: 15199544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of colorectal cancer.
    Gwyn K; Sinicrope FA
    Am J Gastroenterol; 2002 Jan; 97(1):13-21. PubMed ID: 11808936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention of colorectal cancer: feasibility in everyday practice?
    Herszényi L; Farinati F; Miheller P; Tulassay Z
    Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor gamma does not explain the antiproliferative activity of the nonsteroidal anti-inflammatory drug indomethacin on human colorectal cancer cells.
    Hawcroft G; Gardner SH; Hull MA
    J Pharmacol Exp Ther; 2003 May; 305(2):632-7. PubMed ID: 12606626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy.
    Van Geelen CM; de Vries EG; de Jong S
    Drug Resist Updat; 2004 Dec; 7(6):345-58. PubMed ID: 15790545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Other compounds and targets in non-small cell lung cancer.
    Villaflor V; Bonomi P
    Semin Oncol; 2005 Dec; 32(6 Suppl 10):S30-6. PubMed ID: 16459177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of nitric oxide-donating nonsteroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia.
    Rigas B
    Curr Opin Gastroenterol; 2007 Jan; 23(1):55-9. PubMed ID: 17133086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of statin therapy on colorectal cancer.
    Bardou M; Barkun A; Martel M
    Gut; 2010 Nov; 59(11):1572-85. PubMed ID: 20660702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: the chemoprevention of colorectal carcinoma.
    Gasche C
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():31-5. PubMed ID: 15352891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
    Andrews P; Zhao X; Allen J; Li F; Chang M
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer and non-steroidal anti-inflammatory drugs.
    Ota S; Bamba H; Kato A
    Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs.
    Bus PJ; Verspaget HW; Lamers CB; Griffioen G
    Scand J Gastroenterol Suppl; 2000; (232):101-4. PubMed ID: 11232485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of arachidonic acid regulatory enzymes in colorectal disease.
    Abir F; Alva S; Kaminski DL; Longo WE
    Dis Colon Rectum; 2005 Jul; 48(7):1471-83. PubMed ID: 15868226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.
    Hilmi I; Goh KL
    Chin J Dig Dis; 2006; 7(1):1-6. PubMed ID: 16412030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.